The company has technologies that are already registered and commercialized in Russia. In addition to banking services for umbilical cord stem cells, HSCI also provides a service called SPRS-therapy, develops Reprobank sperm and egg bank, as well as the Genetico all-Russian network of medical and genetic counseling. There are some areas related to gene therapy, in particular the gene therapy drug Neovasculgen has been in sales since 2011.

For 10 years our magazine together we have gone from a PDF to a full professional journal indexed by SCOPUS and RISC. All these years, the main sponsor of the edition was Gemabank - personal bank storage of umbilical cord blood. Thanks to it we were able to reproduce the results of domestic research studies in decent quality.